Latest Posts
- Pharma
- August 18, 2026
US appeals court sides with Sun Pharma in Lipitor antitrust case
In an intimation to the stock exchange, the Mumbai-based drugmaker said, “the court of Appeals has affirmed the order of the District Court granting summary judgment in its entirety in…
- Pharma
- August 18, 2026
Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions
New Delhi: Counterfeit cosmetics are no longer a problem confined to a few street markets or isolated raids. A new nationwide consumer survey has delivered another stark warning: 40% of…
- Pharma
- August 17, 2026
Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad
Hyderabad: Three persons were arrested by the Hyderabad Commissioner’s Task Force (Rajendranagar Zone) for selling mephentermine sulphate injections, with police uncovering an online procurement network through which the injections were…
- Pharma
- August 17, 2026
Mumbai Crime Branch cracks down on 5 alleged fake doctors, one found to be only Class 12 pass
Mumbai Crime Branch and BMC medical officers acted against five people allegedly practising medicine without required qualifications or licences in Govandi, Deonar and Bandra. Police seized medical items worth Rs…
- Pharma
- August 17, 2026
DCA raids med shops for violations over sale of weight-loss drugs
Hyderabad: Conducting raids at medical shops across Telangana as part of a special enforcement drive, the Drugs Control Administration (DCA) found violations in the sale of weight-loss drugs at 43…
- Pharma
- August 15, 2026
CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event
Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…
- Pharma
- August 15, 2026
Lilly takes 6 companies to court for selling retatrutide knockoffs
Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…
- Pharma
- August 15, 2026
FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked
Mumbai: The Maharashtra Food and Drug Administration (FDA) on Friday said it busted a racket involved in the illegal purchase and sale of medical abortion kits in Nagpur and Solapur districts…
- Pharma
- August 13, 2026
Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall
Gleneagles BGS Hospital, Kengeri, Bengaluru, part of the Fortis Healthcare Network, marked World Organ Donation Day with its annual commemorative event, ‘A Legacy That Lives On.’ The event brought together…
- Pharma
- August 13, 2026
NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized
Punjab: The Narcotics Control Bureau (NCB) has uncovered an alleged pharmaceutical-drug diversion network operating through rural areas of Punjab. Investigators are tracing the movement of fentanyl and other drugs regulated…
- Pharma
- August 12, 2026
Sun Pharma will Need HC Nod for Semaglutide Tablet Launch
Novo Nordisk submitted that a restraint order was required as Sun Pharma was ready to launch semaglutide tablets in the market the moment it would have marketing approval. And once…
- Pharma
- August 12, 2026
Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines
MUMBAI: The Bombay High Court on Tuesday directed the Maharashtra Food and Drug Administration (FDA) to act “judiciously” after Cadila Pharmaceuticals Ltd challenged orders stopping the sale of some of…
- Pharma
- August 12, 2026
‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits
The Central Drugs Standard Control Organisation (CDSCO) along with State Drugs Controllers (SDCs) have conducted Risk-Based Inspections. NEW DELHI: The Centre on Tuesday said India’s drug regulator has conducted risk-based…
- Pharma
- August 11, 2026
Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses
The inspection revealed incomplete manufacturing records, poor hygiene, inadequate quality-control systems and the omission of ingredients specified in approved Ayurvedic formulations. The Maharashtra Food and Drug Administration (FDA) on Thursday…
- Pharma
- August 11, 2026
Amneal Pharma completes acquisition of Kashiv BioSciences
Amneal Pharmaceuticals, Inc. announced the completion of its acquisition of Kashiv BioSciences, LLC, creating a fully integrated global biosimilars leader with end-to-end capabilities across research, development, manufacturing and commercialization. The…
- Pharma
- August 11, 2026
Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings
New Delhi: The Delhi High Court has ordered the e-commerce platform Meesho to take down listings of allegedly counterfeit sunscreen products of Sun Pharmaceutical Industries Ltd., granting interim relief in…
- Pharma
- August 10, 2026
IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants
GUWAHATI: Indian Institute of Technology Guwahati researchers have developed an optical sensing device that can instantly detect a variety of toxicants in water and other biological samples. Aligned with the Government…
- Pharma
- August 8, 2026
AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha
New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…
- Pharma
- August 7, 2026
NHS backs delayed‑release treatment for cystinosis
Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…
- Hospitals
- August 7, 2026
Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety
AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

US appeals court sides with Sun Pharma in Lipitor antitrust case
Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions
Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad
Mumbai Crime Branch cracks down on 5 alleged fake doctors, one found to be only Class 12 pass
DCA raids med shops for violations over sale of weight-loss drugs
CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event
Lilly takes 6 companies to court for selling retatrutide knockoffs
FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked
Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall
NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized








